Bendazol

This classification denotes a vasodilating agent with the molecular formula C14H12N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26601THN1D, chemically known as 1h-benzimidazole, 2-(phenylmethyl)- (9ci) but generally known as bendazol, which bears US NIH Compound Identifier 12132. Bendazol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bendazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05709MIG. The term BENDAZOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BENDAZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bendazol under HS 29339990 and SITC 51577. As of Q4 2014, BENDAZOL remains the US FDA Preferred Term for this commodity. Bendazol bears US NLM identifiers UMLS ID C2698355 and NCI Concept Code C74427. SMILES: [nH]1c(nc2c1cccc2)Cc1ccccc1.